Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 USD | +0.59% | -0.32% | -3.20% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.20% | 184B | |
-1.86% | 107B | |
-4.32% | 67.78B | |
+0.31% | 50.66B | |
+12.47% | 47.64B | |
+4.60% | 41.12B | |
+1.90% | 26.3B | |
+2.37% | 26.04B | |
+15.06% | 25.4B | |
-1.85% | 24.71B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Earnings Flash (ABT) ABBOTT Posts Q1 Revenue $9.96B, vs. Street Est of $9.87B